ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 127 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,349,000 | -18.5% | 950,129 | +0.5% | 0.00% | 0.0% |
Q3 2016 | $1,655,000 | +2.2% | 945,725 | -0.2% | 0.00% | 0.0% |
Q2 2016 | $1,620,000 | -1.7% | 947,551 | +13.3% | 0.00% | 0.0% |
Q1 2016 | $1,648,000 | +6.6% | 836,603 | +2.8% | 0.00% | 0.0% |
Q4 2015 | $1,546,000 | -0.8% | 813,789 | -0.3% | 0.00% | 0.0% |
Q3 2015 | $1,558,000 | -59.1% | 815,877 | -0.6% | 0.00% | -60.0% |
Q2 2015 | $3,807,000 | +30.4% | 820,461 | +22.8% | 0.01% | +25.0% |
Q1 2015 | $2,920,000 | +40.2% | 668,239 | +11.4% | 0.00% | +33.3% |
Q4 2014 | $2,082,000 | -17.8% | 599,904 | -0.8% | 0.00% | -25.0% |
Q3 2014 | $2,533,000 | -28.1% | 604,639 | +0.6% | 0.00% | -20.0% |
Q2 2014 | $3,523,000 | -9.6% | 601,165 | -2.9% | 0.01% | -16.7% |
Q1 2014 | $3,899,000 | +8.3% | 618,938 | +0.5% | 0.01% | +20.0% |
Q4 2013 | $3,601,000 | +8.3% | 615,624 | -2.5% | 0.01% | 0.0% |
Q3 2013 | $3,326,000 | -27.8% | 631,159 | +5.5% | 0.01% | -37.5% |
Q2 2013 | $4,608,000 | – | 598,385 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 1,567,700 | $9,877,000 | 3.29% |
Lyons Wealth Management, LLC. | 56,775 | $359,000 | 0.31% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,216,579 | $7,664,000 | 0.31% |
Alpha Cubed Investments, LLC | 50,797 | $320,000 | 0.17% |
SABBY MANAGEMENT, LLC | 215,700 | $1,359,000 | 0.08% |
OppenheimerFunds, Inc. | 7,000,000 | $44,100,000 | 0.05% |
PROFUND ADVISORS LLC | 181,051 | $1,141,000 | 0.05% |
Brown Advisory Securities, LLC | 20,000 | $126,000 | 0.05% |
WELLINGTON MANAGEMENT GROUP LLP | 27,549,128 | $173,561,000 | 0.05% |
MURPHY CAPITAL MANAGEMENT INC | 45,000 | $283,000 | 0.05% |